US Patent Issued to DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS on Aug. 11 for "Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy" (German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,704,512, issued on Aug. 11, was assigned to DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Heidelberg, Germany).

"Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy" was invented by Peter H. Krammer (Heidelberg, Germany), Alexandra Kurz (Kiel, Germany), Bjorn Linke (Jena, Germany) and Heiko Weyd (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for identifying a compound that modulates the interaction of an annexin core domain with a receptor selected from the group of C-type lectin receptors and LRP-1 in a cell, a...